We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $618B
1-Year Est. Return 30.34%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
+4.67%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+433.28%
AUM
$489B
AUM Growth
+$8.01B
Cap. Flow
-$30B
Cap. Flow %
-6.13%
Top 10 Hldgs %
29.25%
Holding
15,615
New
1,894
Increased
5,213
Reduced
6,341
Closed
1,909

Top Sells

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$1.71B
2
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$613M
3
AAPL icon
Apple
AAPL
+$478M
4
MA icon
Mastercard
MA
+$450M
5
QQQ icon
Invesco QQQ Trust
QQQ
+$424M

Sector Composition

Rank Sector Weight
1 Technology 3.07%
2 Financials 2.32%
3 Consumer Discretionary 2.2%
4 Healthcare 2.2%
5 Communication Services 1.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NPKI
12501
CALL
NPK International
NPKI
$1.16B
$110K ﹤0.01%
37,300
+400
+1% +$1.28K
AKTS
12502
PUT
DELISTED
Akoustis Technologies Inc
AKTS
$110K ﹤0.01%
16,500
-14,300
-46% -$107K
NMTR
12503
DELISTED
9 Meters Biopharma
NMTR
$110K ﹤0.01%
5,598
-3,822
-41% -$85.5K
GSQD.U
12504
DELISTED
G Squared Ascend I Inc. Units, each consisting of one Class A ordinary share and one-fifth of one Warrant to acquire one Class A ordinary share
GSQD.U
$110K ﹤0.01%
10,927
-302
-3% -$3.05K
CTT
12505
PUT
DELISTED
CATCHMARK TIMBER TRUST, INC.
CTT
$110K ﹤0.01%
+12,600
New +$112K
CLRB icon
12506
Cellectar Biosciences
CLRB
$20.7M
$109K ﹤0.01%
+549
New +$132K
RCAT icon
12507
PUT
Red Cat Holdings
RCAT
$1.33B
$109K ﹤0.01%
+52,200
New +$130K
SEAT icon
12508
PUT
Vivid Seats
SEAT
$91.3M
$109K ﹤0.01%
+500
New +$118K
WIMI
12509
PUT
WiMi Hologram Cloud
WIMI
$23.2M
$109K ﹤0.01%
3,570
-10,070
-74% -$407K
WWR icon
12510
PUT
Westwater Resources
WWR
$53.6M
$109K ﹤0.01%
50,900
+31,700
+165% +$96.9K
HT
12511
PUT
DELISTED
Hersha Hospitality Trust Priority Class A Common Shares of Beneficial Interest
HT
$109K ﹤0.01%
11,900
-26,900
-69% -$254K
OTIC
12512
CALL
DELISTED
Otonomy, Inc.
OTIC
$109K ﹤0.01%
52,200
-14,100
-21% -$29K
QTNT
12513
CALL
DELISTED
Quotient Limited Ordinary Shares
QTNT
$109K ﹤0.01%
+1,053
New +$101K
LMAOU
12514
DELISTED
LMF Acquisition Opportunities Inc. Unit
LMAOU
$109K ﹤0.01%
10,467
-418
-4% -$4.36K
TCACU
12515
DELISTED
Tuatara Capital Acquisition Corporation Unit
TCACU
$109K ﹤0.01%
10,747
-1,009
-9% -$10.2K
HCCCU
12516
DELISTED
Healthcare Capital Corp. Unit
HCCCU
$109K ﹤0.01%
+10,773
New +$110K
GCACU
12517
DELISTED
Growth Capital Acquisition Corp. Unit
GCACU
$109K ﹤0.01%
10,656
-162
-1% -$1.68K
CALC icon
12518
CalciMedica
CALC
$12.4M
$108K ﹤0.01%
4,234
-1,592
-27% -$61.8K
CARM
12519
CALL
DELISTED
Carisma Therapeutics
CARM
$108K ﹤0.01%
6,650
-1,685
-20% -$33.9K
CELU icon
12520
PUT
Celularity
CELU
$20.5M
$108K ﹤0.01%
2,110
-2,250
-52% -$144K
TK icon
12521
PUT
Teekay
TK
$956M
$108K ﹤0.01%
34,500
-40,500
-54% -$140K
ATYR
12522
CALL
aTyr Pharma
ATYR
$50.3M
$108K ﹤0.01%
14,400
-6,000
-29% -$50.1K
ALPP
12523
PUT
DELISTED
Alpine 4 Holdings Inc
ALPP
$108K ﹤0.01%
+7,063
New +$157K
TBCPW
12524
DELISTED
Thunder Bridge Capital Partners III Inc. Warrant
TBCPW
$108K ﹤0.01%
130,291
-89,005
-41% -$77.2K
MTEM
12525
CALL
DELISTED
Molecular Templates, Inc.
MTEM
$108K ﹤0.01%
1,840
+773
+72% +$57.9K

Similar funds

Citadel Advisors's Q4 2021 Portfolio in Review

As of Q4 2021, Citadel Advisors held 15,615 positions worth $489B, up 1.7% from $481B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Citadel Advisors withdrew a net $30B in Q4 2021, closing 1,909 positions and reducing 6,341 holdings. Its most notable exit was CIMAREX ENERGY CO, an estimated $279M position sold in full.

By sector, the portfolio is most concentrated in Technology at 3.1% of assets, up from 3% a quarter earlier, followed by Financials and Consumer Discretionary.

Against the trend, Citadel Advisors opened a new position in iShares iBoxx $ High Yield Corporate Bond ETF worth $248M.

  • Citadel Advisors's largest Q4 2021 buy was iShares iBoxx $ High Yield Corporate Bond ETF: 2,847,920 shares worth $248M.
  • Citadel Advisors added most to Amazon in Q4 2021, an estimated $802M increase.
  • Citadel Advisors's biggest Q4 2021 reduction was Tesla, cutting an estimated $1.71B.
  • Citadel Advisors fully exited CIMAREX ENERGY CO in Q4 2021, selling an estimated $279M.
  • Citadel Advisors's ten largest holdings make up 29% of its $489B portfolio in Q4 2021.
  • Citadel Advisors opened 1,894 new positions and closed 1,909 in Q4 2021.
  • Citadel Advisors's portfolio value rose 1.7% quarter-over-quarter to $489B.

Based on Citadel Advisors's 13F filing for Q4 2021, filed 14 Feb 2022.